- Report
- January 2023
- 168 Pages
Asia Pacific
From €3114EUR$3,450USD£2,700GBP
- Report
- November 2022
- 220 Pages
Global
From €4016EUR$4,450USD£3,482GBP
- Report
- May 2022
- 240 Pages
Global
From €4016EUR$4,450USD£3,482GBP
- Report
- April 2024
- 300 Pages
Global
From €4016EUR$4,450USD£3,482GBP
- Report
- November 2023
- 185 Pages
Global
From €4016EUR$4,450USD£3,482GBP
- Report
- April 2025
- 43 Pages
Global
From €1083EUR$1,200USD£939GBP
- Drug Pipelines
- February 2023
- 35 Pages
Global
From €18042EUR$19,990USD£15,642GBP
- Report
- January 2024
- 150 Pages
Global
€4508EUR$4,995USD£3,908GBP
- Report
- December 2025
- 150 Pages
Germany
From €4377EUR$4,850USD£3,795GBP
- Report
- November 2025
- 150 Pages
Japan
From €4377EUR$4,850USD£3,795GBP
- Report
- November 2025
- 150 Pages
China
From €4377EUR$4,850USD£3,795GBP
- Report
- June 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- September 2024
- 150 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- September 2024
- 150 Pages
Global
From €4377EUR$4,850USD£3,795GBP
- Report
- August 2024
- 140 Pages
Global
From €3565EUR$3,950USD£3,091GBP
- Report
- January 2024
- 146 Pages
Global
From €3836EUR$4,250USD£3,325GBP
- Report
- December 2023
- 145 Pages
Global
From €4016EUR$4,450USD£3,482GBP
- Report
- December 2023
- 148 Pages
Global
From €4016EUR$4,450USD£3,482GBP
- Report
- November 2023
- 306 Pages
Global
From €3249EUR$3,600USD£2,817GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more